There were 1,109 press releases posted in the last 24 hours and 468,443 in the last 365 days.

How CBD May Affect COVID-19 Focus of Talk at Online Medical Conference

Cannabinoids and Adaptive Immunomodulation

Longevity, Ageing, and Immuno-Competency Virtual Conference

Dr. Jeffrey S. Block, M.D.

Dr. Jeffrey S. Block, M.D.

Nurturing Nature Studio

Nurturing Nature Studio

Clinician and Botanical Medicine Expert Jeffrey S. Block, M.D. Featured at A4M Event

MIAMI, FLORIDA, USA, August 20, 2020 / -- Jeffrey S. Block, M.D. will explain how cannabinoids can modulate the immune response in ways
that affect the novel coronavirus on Saturday, August 22 at 3:00 pm (EDT) during a virtual talk
before the American Academy of Anti-Aging Medicine (A4M). The potential of cannabis to treat
COVID-19 is why a provision related to medical marijuana was included in the pandemic relief
bill passed by the House, according to Speaker Nancy Pelosi.

Dr. Block, a leading expert on the clinical applications of cannabis, will address why the natural
human endogenous cannabinoid system (ECS) may be an effective target for treatment in
COVID-19. His talk will address the ethics of clinical decision making, the critical role the ECS
plays in modulating inflammation and immune function, and the differences in the effect of the
dominant chemicals in cannabis.

“Jeff Block combines decades of clinical patient experience with an exceptional understanding of
the cannabis plant and the bodily systems on which it operates” said Mahmoud A. ElSohly,
Ph.D., the longtime director of the Marijuana Project at the University of Mississippi, which
is funded by the National Institute on Drug Abuse and produces all research cannabis in the
U.S. “His ability to clearly communicate the implications for patient care of scientific
discoveries make this a talk not to miss.”

Dr. Block’s presentation is part of A4M’s two-day online conference, “Medicine Revolutionized
- Longevity, Aging and Immuno-Competency” August 21-22. The live-stream conference
provides a strategic clinical roadmap for clinicians seeking to improve patient health spans,
relieve unwanted ageing symptoms, and strengthen immune competency. Attendees will be able
to ask questions of faculty and will receive up to 11.75 AMA PRA Category 1 credits through
The George Washington University School of Medicine and Health Sciences.

WHO: Jeffrey S. Block, M.D.
WHAT: Presentation on cannabinoids’ potential for treating COVID-19
WHEN: Saturday, August 22; 3:00 pm Eastern Daylight Time
WHERE: Online at

ABOUT: A nationally recognized speaker, Dr. Jeffrey S. Block is the author of “Endogenous
Cannabinoid Receptors and Medical Cannabis” in Advanced Therapeutics in Pain Medicine,
forthcoming from CRC Press January 2021. Dr. Block is a board-certified anesthesiologist and
an authority on health-care and plants. He has served as the Florida Medical Association’s
designated expert on botanical medicines, authored the state’s mandated physician education,
and was appointed to write the Florida Department of Health’s rules for the state’s
Compassionate Medical Cannabis Act of 2014. He has taught at the University of Miami’s
Miller School of Medicine and is the founding partner of Nurturing Nature® Group Consultants.

The American Academy of Anti-Aging Medicine (A4M) is a non-profit that holds two annual
World Congresses, each of which hosts 3,000 to 5,000 physicians and healthcare practitioners.

Dr Jeffrey S. Block
Nurturing Nature
+1 305 793 9222
email us here
Visit us on social media: